Denali Therapeutics Inc.
Symbool: DNLI
NASDAQ
20.86
USDMarktprijs vandaag
-14.6885
Koers/Winst Verhouding
-0.1573
Koers/Winst Groei Verhouding
2.88B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Denali Therapeutics Inc. Structuur van het management
Informatie over het management
Naam | Titel |
---|---|
Mr. Joe Lewcock Ph.D. | Chief Scientific Officer |
Mr. Tyler M. Nielsen | Senior Vice President of Corporate Finance |
Dr. Dana Andersen | Chief Technical and Manufacturing Officer |
Dr. Ryan J. Watts Ph.D. | Co-Founder, President, Chief Executive Officer & Director |
Dr. Carole Ho M.D. | Chief Medical Officer & Head of Development |
Dr. Laura Hansen | Vice President of Investor Relations |
Dr. Marc Tessier-Lavigne Ph.D. | Co-Founder & Independent Director |
Mr. Chris Walsh | General Counsel |
Mr. Mark Rowen | Vice President of Corporate Development |
Dr. Alexander O. Schuth M.D. | Co-Founder, Chief Financial Officer, Chief Operating Officer & Secretary |
Vergelijkbare aandelen
Misschien ben je ook geïnteresseerd in:MRVI
Topmanagement:
- Ms. Debra Hart
- Ms. Rebecca Buzzeo
- Dr. Kate E. Brode...
CMRA
Topmanagement:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
T5O.DE
Topmanagement:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
HBC.OL
Topmanagement:
- Dr. Crawford Lind...
- Mr. James Berger
- Ms. Angelika Flo...
PPBT
Topmanagement:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...
SPHRF
Topmanagement:
- Ms. Cheryl Maley...
- Mr. Justin Cahill